Vanta Bioscience Ltd Ordinary Shares

540729

Summary

Fair Value Assessment
Undervalued (18% Discount)
Fair ValueQ37.50UncertaintyHigh
Close Price30.44Feb 27, 2025
Market Closed
30.44
Price Up by 1.44 | 4.97 %
Previous Close
30.44
Day Range
30.44 – 30.44
Year Range
29.00 – 101.64
Bid / Ask
Market Cap
192.1 Mil
Volume / Average
750.0 / 3.3 k
Beta (5-Year)
0.66
Shares Outstanding
6.31 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.
Contact
No. 02/G/308/G, Umajay Complex No. 3/FF/SF/1-20-248, Secunderabad, TG 500003
T +91 4066575454
www.vantabio.com opens in a new tab
Sector
Healthcare
Industry
Diagnostics & Research
Most Recent Earnings
Sep 30, 2024
Fiscal Year End
Mar 31, 2025
Employees
48

Key Metrics

Income Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
45.77 97.23 62.76 96.87 100.38 141.43
Revenue Growth %
-52.46% 54.92% -35.22% -3.50% -29.02% 13.83%
Gross Profit
59.05 89.71 52.87 89.18 91.94 128.79
Gross Profit Margin %
92.27% 84.25% 92.06% 91.58% 91.06%
Operating Income
-57.56 -31.65 -50.64 21.52 27.48 31.80
Operating Margin %
-125.74% -32.55% -80.69% 22.22% 27.37% 22.49%
EBIT
-57.43 -31.62 -47.17 27.63 26.50 32.61
EBIT Margin %
-125.46% -32.52% -75.16% 28.52% 26.40% 23.06%
EBITDA
-11.02 13.35 -20.47 40.79 39.01 44.50
EBITDA Margin %
-24.08% 13.73% -32.61% 42.10% 38.87% 31.47%
Net Income
-38.48 -23.16 -64.81 0.88 4.50 10.05
Net Profit Margin %
-228.48% -88.52% -166.43% 1.39% 4.47% 7.16%
Basic EPS
-6.10 -3.67 -10.27 0.14 0.71 1.59
Diluted EPS
-6.10 -3.67 -10.27 0.14 0.71 1.59
Normalized EPS
Total Dividends per Share
Balance Sheet (in Mil, except ratios)
03/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
853.97 853.97 847.09 814.04 696.29 485.75
Total Liabilities
724.23 724.23 657.79 520.60 434.02 241.16
Total Debt
611.16 611.16 571.61 448.67 359.70 173.69
Total Equity
129.73 129.73 189.30 293.44 262.27 244.59
Cash And Cash Equivalents
1.61 1.61 0.97 2.24 26.50 1.95
Working Capital
-57.16 -57.16 -25.04 -32.60 50.93 99.73
Shares Outstanding (Mil)
6.31 6.31 6.31 6.31 6.31
Book Value Per Share
24.08 24.08 27.75 38.03 37.89 37.18
Total Debt To Equity
4.71 4.71 3.02 1.53 1.37 0.71
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-8.74 26.84 -6.28 52.79 69.72 23.41
Cash From Investing Activities
-32.98 -33.13 -59.09 -171.81 -221.94 -73.52
Cash From Financing Activities
41.64 6.93 64.09 95.32 177.81 21.75
Capital Expenditures
33.90 34.05 286.89 171.81 221.94 73.52
Free Cash Flow
-94.94 -77.77 -362.82 -156.36 -203.75 -48.21
Change in Cash
-0.09 0.64 -1.28 -23.70 25.58 -28.36

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top